Hui‐Peng Lee
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 10
- Chronic Lymphocytic Leukemia Research 10
-
- Lymphoma Diagnosis and Treatment 13
- Co-authors
- Jia Li (1 shared paper)Rémy Gressin (1 shared paper)Keith C. Fay (1 shared paper)Javier L Munoz (1 shared paper)David Belada (1 shared paper)René-Olivier Casasnovas (1 shared paper)Morton Coleman (1 shared paper)Douglas James DeMarini (1 shared paper)
- Journals
- Blood Advances (3 papers)Journal of Clinical Oncology (2 papers)Blood (2 papers)The Lancet (1 paper)Hematological Oncology (1 paper)
- Partner nations
- AustraliaUnited StatesCzechia
In The Last Decade
Hui‐Peng Lee
15 papers receiving 652 citations
Hui‐Peng Lee's Hit Papers
Peers
Comparison fields: 5 of 42
- Genetics 487
- Pathology and Forensic Medicine 378
- Hematology 128
- Immunology 121
- Oncology 142
Countries citing papers authored by Hui‐Peng Lee
This map shows the geographic impact of Hui‐Peng Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Peng Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Peng Lee more than expected).
Fields of papers citing papers by Hui‐Peng Lee
This network shows the impact of papers produced by Hui‐Peng Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Peng Lee. The network helps show where Hui‐Peng Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui‐Peng Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study Hit paper breakdown → | 2020 | 365 |
| 2 | 2023 | 77 | |
| 3 | 2020 | 70 | |
| 4 | 2020 | 32 | |
| 5 | 2020 | 32 | |
| 6 | 2024 | 26 | |
| 7 | 2025 | 23 | |
| 8 | 2024 | 13 | |
| 9 | 2021 | 6 | |
| 10 | 2023 | 5 | |
| 11 | 2019 | 4 | |
| 12 | 2025 | 4 | |
| 13 | 2024 | 2 | |
| 14 | 2021 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 1 |
About Hui‐Peng Lee
Hui‐Peng Lee is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Hematology and Neurology, having authored 16 papers that have together received 662 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (10 papers), Viral-associated cancers and disorders (4 papers), Chronic Myeloid Leukemia Treatments (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), CAR-T cell therapy research (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Genetics (487 citations), Pathology and Forensic Medicine (378 citations), Hematology (128 citations), Immunology (121 citations) and Oncology (142 citations). Hui‐Peng Lee has collaborated with scholars based in Australia, United States and Czechia. Frequent co-authors include Jia Li, Rémy Gressin, Keith C. Fay, Javier L Munoz, David Belada, René-Olivier Casasnovas, Morton Coleman, Douglas James DeMarini, Amitkumar Mehta and Gregor E. G. Verhoef. Their work appears in journals such as Blood Advances, Journal of Clinical Oncology, Blood, The Lancet and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.